Latest oppositions filed by Dr. H. Ulrich Dorries

This table presents recent patent oppositions filed by Dr. H. Ulrich Dorries against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3791896Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of CancerASTELLAS PHARMA INC.Oct 10, 2024
EP3973987Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS, INC.Oct 1, 2024
EP3703818Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS, INC.Aug 1, 2024
EP4011915Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS, INC.Jul 3, 2024
EP3311168Novel Tnf Structure For Use In TherapyUCB BIOPHARMA SPRLFeb 12, 2024
EP3827845Subcutaneous Formulations Of Anti-Cd38 Antibodies And Their UsesJANSSEN BIOTECH, INC.Dec 22, 2022
EP3157571Fatty Acids And Their Use In Conjugation To BiomoleculesNOVARTIS AGAug 24, 2022
EP3209783Permanent Epigenetic Gene SilencingFONDAZIONE TELETHONAug 24, 2022
EP3470432Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS, INC.Jul 5, 2022
EP3107575Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS, INC.May 4, 2022